• The role of proteomics and metabolomics in human atlases & disease models
• Using proteomic & metabolomic data to find disease mechanisms
• Developing and maintaining large scale cell and organ atlas projects
Moderator:
YEA JIN KAESER-WOO, Senior Director, Next Generation Therapeutics, Eli Lilly
Panellists:
EMRE ARSLAN, Associate Director, Takeda
JIA-REN LIN, Technical Director, Tissue Imaging Platform, Harvard Medical School
DAVID GALLEGOS, Senior Scientist, Takeda
AHMET COSKUN, Professor of Biomedical Engineering, Georgia Institute of Technology
